Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4A | P27815 | 16/20 | 0.50 |
| ▸ | ADRB1 | P08588 | 2/20 | 0.49 |
| ▸ | ADRB3 | P13945 | 2/20 | 0.49 |
| ▸ | PDE4D | Q08499 | 6/20 | 0.47 |
| ▸ | PDE4B | Q07343 | 5/20 | 0.47 |
| ▸ | PDE4C | Q08493 | 5/20 | 0.47 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.43 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6465669 | 0.85 | PDE4A (0.51) | PDE4APDE4DPDE4BPDE4C | |
| SCHEMBL2929760 | 0.84 | PDE4A (0.49) | PDE4APDE4DPDE4BPDE4CMKNK1 | |
| SCHEMBL4196752 | 0.83 | PDE4A (0.55) | PDE4AADRB1ADRB3PDE4DPDE4B | |
| SCHEMBL6469266 | 0.83 | PDE4A (0.49) | PDE4APDE4DPDE4BPDE4CMKNK1 | |
| SCHEMBL4830414 | 0.79 | PDE4A (0.47) | PDE4AADRB1ADRB3PDE4DPDE4B | |
| SCHEMBL3130695 | 0.79 | PDE4A (0.54) | PDE4APDE4DPDE4BPDE4C | |
| SCHEMBL4199336 | 0.78 | PDE4A (0.54) | PDE4APDE4DPDE4BPDE4CMKNK1 | |
| SCHEMBL6527339 | 0.77 | PDE4A (0.47) | PDE4AADRB1ADRB3PDE4DPDE4B | |
| SCHEMBL6470078 | 0.77 | PDE4A (0.49) | PDE4APDE4DPDE4BPDE4C | |
| SCHEMBL6533002 | 0.76 | PDE4A (0.46) | PDE4APDE4DPDE4BPDE4C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1569908-A2 | PYRIDINE N-OXIDE COMPOUNDS AS PHOSPHODIESTERASE 4 INHIBITORS | Memory Pharmaceutical Corporation (US) | 2005-09-07 | — | — | EP | claimed |
| WO-2004046113-A2 | PYRIDINE N-OXIDE COMPOUNDS AS PHOSPHODIESTERASE 4 INHIBITORS | MEMORY PHARMACEUTICALS CORPORATION (US) | 2004-06-03 | — | — | WO | claimed |
| EP-1569908-A2 | PYRIDINE N-OXIDE COMPOUNDS AS PHOSPHODIESTERASE 4 INHIBITORS | Memory Pharmaceutical Corporation (US) | 2005-09-07 | — | — | EP | disclosed |
| WO-2004046113-A2 | PYRIDINE N-OXIDE COMPOUNDS AS PHOSPHODIESTERASE 4 INHIBITORS | MEMORY PHARMACEUTICALS CORPORATION (US) | 2004-06-03 | — | — | WO | disclosed |